Neural Stem Cells Therapy for Cerebral Palsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the safety and efficacy of neural stem cells (NSCs) therapy for cerebral palsy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transplantation of Umbilical Cord-derived Mesenchymal Stem Cells Via Different Routes

NCT03414697

Cerebral Palsy

UNKNOWN NA

Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy

NCT03078621

Cerebral Palsy

UNKNOWN PHASE1/PHASE2

Sensorimotor Control During Postural Transitions in CP

NCT05384990

Cerebral Palsy

ACTIVE_NOT_RECRUITING NA

Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy

NCT03795974

Cerebral Palsy, Spastic

UNKNOWN PHASE2

Effect of Rhythmic Auditory Stimulation on Balance in Children With Cerebral Palsy.

NCT05455970

Cerebral Palsy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cerebral palsy is the most severe lifelong disability disease in childhood. In China, an epidemiological investigation of cerebral palsy in 2004 has reported that 2.74‰ (about 6.50-9.75 million) of children suffered from cerebral palsy. The costs of medical expenses, living allowance and nursing care can go up to RMB 20000-50000 yuan per year for each child with cerebral palsy and thus China will expend RMB 120-300 billion yuan per year for children with cerebral palsy. With full liberalization of two-child policy, there is an increasing number of second babies born to women who are 35 years or older. Thus, the incidence of cerebral palsy tends to increase. There is currently no cure for cerebral palsy, resulting in a heavy burden for families and on society. Recent clinical trials performed in countries outside China have demonstrated that stem cell therapy is likely the most effective method to treat cerebral palsy. Fifteen trials regarding stem cell therapy for cerebral palsy have been registered with ClinicalTrials.gov. In China, there have been no standardized registered trials regarding stem cell therapy for cerebral palsy, which greatly restricts its clinical application. In October 2016, the National Health and Family Planning Commission and the Food and Drug Administration of China jointly announced the premier stem cell clinical research institutions, making performing standardized trials regarding stem cell therapy for cerebral palsy in China possible.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

neural stem cells therapy group

The patients will be assigned to neural stem cells therapy group for cerebral palsy.

Group Type EXPERIMENTAL

neural stem cells therapy group

Intervention Type PROCEDURE

The patients will be assigned to neural stem cells therapy group for cerebral palsy.

the control group

The patients will be assigned to the control group for cerebral palsy.

Group Type EXPERIMENTAL

the control group

Intervention Type OTHER

The patients will be assigned to the control group for cerebral palsy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

neural stem cells therapy group

The patients will be assigned to neural stem cells therapy group for cerebral palsy.

Intervention Type PROCEDURE

the control group

The patients will be assigned to the control group for cerebral palsy.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neonates with ischemic/hypoxic cerebral palsy (mainly including neonate with asphyxia and premature infants);
* Clinical manifestation of spastic tetraplegia;
* With moderate to severe cerebral palsy, The Gross Motor Function; Classification System (GMFCS) levels IV-V;
* Age 1-5 years, of either sex;
* Provision of signed informed consent by one of his/her parents or legal guardians prior to commencement of this study;

Exclusion Criteria

* Systemic diseases that possibly influence treatment or patient's compliance;
* Potentially life-threatening diseases involving various organ systems;
* Brain deformity;
* Abnormal behaviors or mood disorder;
* Allergies from blood products;
* Suffering from infectious disease;
* Subjected to craniocerebral operations prior to screening.

Minimum Eligible Age

1 Year

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No